Navigation Links
FDA Extends Review Timeline for Additional Indication for Antibiotic DORIBAX(TM)
Date:3/6/2008

RARITAN, N.J., March 6 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., today announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline for the second New Drug Application for the antibiotic DORIBAX(TM) (doripenem for injection). The application, submitted in June 2007, seeks approval to market DORIBAX to treat nosocomial, or "hospital-acquired," pneumonia and ventilator-associated pneumonia, which occurs in patients who are on mechanical ventilation because they cannot breathe on their own.

The FDA extended the review period by three months to provide time for a full review of the application after receiving additional information it had requested from the company.

DORIBAX is already FDA-approved to treat complicated urinary tract and complicated intra-abdominal infections and is marketed by Ortho-McNeil(TM), Division of Ortho-McNeil-Janssen Pharmaceutical Services, Inc., in the U.S. The use of DORIBAX to treat complicated urinary tract and complicated intra-abdominal infections and nosocomial pneumonia, including ventilator-associated pneumonia, currently is under regulatory review in Europe, Canada and in other countries. DORIBAX is licensed from Shionogi & Co., Ltd.

INDICATIONS

DORIBAX is indicated as a single agent for the treatment of: complicated intra-abdominal infections caused by susceptible strains of E. coli, K. pneumoniae, P. aeruginosa, B. caccae, B. fragilis, B. thetaiotaomicron, B. uniformis, B. vulgatus, S. intermedius, S. constellatus or P. micros, and for the treatment of complicated urinary tract infections, including pyelonephritis, caused by susceptible strains of E. coli, including cases with concurrent bacteremia, K. pneumoniae, P. mirabilis, P. aeruginosa, or A. baumannii.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of DORIBAX and other antibacterial drugs, DORIBAX should be used only to treat in
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development,L.L.C.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Siemens Extends Tender Offer for Acquisition of Dade Behring
2. Global Med Technologies(R) Extends Its Worldwide Outreach
3. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
4. NIH/NCI renews and extends nationwide license for Genomatix software and databases
5. Design Resource Extends Support for Orthopaedic and Cardiovascular Devices
6. Kerry Extends, Improves Small Business Innovation Program
7. amfAR Appoints New Leadership as AIDS Research Organization Extends Its Global Reach
8. Emdeon Business Services Extends Market Leadership With New Dental Eligibility Payers
9. QMed, Inc. Extends Agreement & Receives $550,000 Performance Bonus
10. Roche Extends Tender Offer for Ventana
11. Oncology Physician Resource (OPR) Extends Agreement With OTN and Onmark as Oncology Services Partner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... project SOPHIE has evaluated the relationship between the ... health in Europe. The results show that countries ... and countries with contradictory policies (Eastern Europe), present ... poorer health than men. Health inequalities are especially ... a 27% higher risk of having poor health ...
(Date:7/28/2014)... New Port Richey, FL (PRWEB) July 28, 2014 ... “a silent killer,” prescription drug abuse causes more fatal ... than 16,500 lives a year. (1) Those who are ... (65 years of age and up), with many in ... daily. (2) Conversation regarding this growing epidemic was reawakened ...
(Date:7/28/2014)... Karen Pallarito HealthDay Reporter ... taxpayers who go without health insurance this year will face ... a family of five, the Internal Revenue Service says. ... the federal tax penalties that some Americans will owe for ... is based on the monthly national average premium for a ...
(Date:7/28/2014)... July 28, 2014 "We experienced difficulty ... said one of two inventors from Jamestown, Calif. "We ... open so that we could pour medications in more ... STAY OPEN to keep the lids open as the ... closing until all compartments have been filled. This eliminates ...
(Date:7/28/2014)... Health Center of Snohomish County (CHC), a non-profit provider ... an article designed to educate patients about the opportunity ... the health center has a strong focus on providing ... to obtaining high quality yet affordable healthcare services. ... here: http://www.chcsno.org/locations.ashx?p=1099 , The article begins by ...
Breaking Medicine News(10 mins):Health News:Gender inequalities in health: A matter of policies 2Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 2Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 3Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 4Health News:IRS Caps Fines on Uninsured Americans at $12K for Family of 5 2Health News:Community Health Center of Snohomish Releases Article Focusing on Educating the Chronically Ill About Chronic Disease Management 2Health News:Community Health Center of Snohomish Releases Article Focusing on Educating the Chronically Ill About Chronic Disease Management 3
... concerns about erosion of RN and patient care ... today criticized the action by the Service Employees ... affiliate, United Healthcare Workers-West.In a statement today, Rose ... registered nurses in most of the hospitals where ...
... called astrocytes help to cause the urge to sleep that ... funded by the National Institutes of Health. The cells ... are inhibited by caffeine. , "Millions of Americans suffer from ... from pilots to combat soldiers have jobs where sleepiness ...
... Wednesday,s winter storm has impacted the blood ... blood drives were cancelled or postponed on Wednesday ... appointments, resulting in a 32.5% reduction of Penn-Jersey ... 6 blood drives that were scheduled to collect ...
... help spread awareness of Foundation,s mission and servicesSHORT HILLS, ... Foundation, the national, non-profit organization dedicated to finding cures ... lives of people living with paralysis, announced today that ... show "Brothers and Sisters," has been named a celebrity ...
... over 20 now have the condition, while 30% are pre-diabetic, ... most recent analysis of data on diabetes in the United ... and older have the condition, 40 percent of whom have ... patients than noted in a previous study, although the percentage ...
... Washington, D.C. A three-year award from the ... of Population Affairs to Georgetown University,s Institute for ... in California and Massachusetts to offer the Standard ... planning method developed by Institute researchers. , In ...
Cached Medicine News:Health News:CNA/NNOC Criticizes SEIU Trusteeship: Cites Concerns for Erosion of RN and Patient Care Standards 2Health News:Support cells, not neurons, lull the brain to sleep 2Health News:Support cells, not neurons, lull the brain to sleep 3Health News:Blood Donors Needed in Wake of Winter Storm 2Health News:Dave Annable Named Christopher & Dana Reeve Foundation Ambassador 2Health News:Diabetes Keeps Rising Among U.S. Adults 2Health News:Diabetes Keeps Rising Among U.S. Adults 3Health News:Bringing easy-to-use, effective natural family planning to American women 2
(Date:7/28/2014)... WELLINGTON, New Zealand , July 28, 2014 ... Institute in Sweden has ... across multiple vendor platforms and has associated volumetrically ... Published in Cancer Epidemiology, Biomarkers & Prevention ... volumetric mammographic density: a tool for widespread breast ...
(Date:7/28/2014)... HOUSTON , July 28, 2014  Houston ... announces that he offers orthodontic treatment with Invisalign. ... area patients can have their teeth straightened without ... same long-term benefits associated with other types of ... enjoy natural looks in addition to better support ...
(Date:7/28/2014)... , July 28, 2014  TNI BioTech, ... biopharmaceutical company focused on the development, marketing and ... has filed definitive proxy materials with the Securities ... Annual Meeting of Shareholders to be held on ... Standard Time. The record date for determining those ...
Breaking Medicine Technology:Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4Houston Cosmetic Dentist, Dr. Behzad Nazari, Now Offers Orthodontic Treatment with Invisalign 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3
... Incorporated (NYSE: DGX ), the world,s leading ... it is scheduled to speak at the Jefferies 2011 ... is scheduled for Monday, June 6, 2011 at 8:30 ... webcast live during the conference and will be available ...
... ANN ARBOR, Mich., June 3, 2011 Everist Genomics ... OncoDefender-CRC assay, a molecular prognostic test for early-stage colorectal ... Society of Clinical Oncology (ASCO) Annual Meeting, which will ... (Logo: http://photos.prnewswire.com/prnh/20110110/NY26865LOGO ) OncoDefender-CRC examines expression ...
Cached Medicine Technology:Everist Genomics Announces New Data on OncoDefender™- CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients 2Everist Genomics Announces New Data on OncoDefender™- CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients 3Everist Genomics Announces New Data on OncoDefender™- CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients 4
A simple, one-piece design eliminates seams that irritate and also extend the life of the collar. Comes with extra long Velcro closure to fit all. Also available with trim. One size fits all. Availab...
Designed to be removed from under surgical gown without compromising sterile fields. Two straps criss-cross in the back and attach with velcro in the front....
... Like our coat apron, weight ... allowing hours of comfortable wear without ... body movement, our front closing special ... access "Velcro closures that make it ...
... Easy Wrap Apron has always been ... easy to put-on, adjust and take-off. ... comfortable! The new Easy sures Wrap ... the fit more easily. The attached ...
Medicine Products: